nach oben

World Journal of Urology

Erschienen in:

02.01.2019 | Letter to Editor

Furthering the external validity of Aquablation and implications for real-world patients

verfasst von: David-Dan Nguyen, Naeem Bhojani, Kevin C. Zorn

Erschienen in: World Journal of Urology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

McCulloch P, Altman DG, Campbell WB et al (2009) No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374(9695):1105–1112. https://doi.org/10.1016/S0140-6736(09)61116-8 PubMedCrossRef

Gilling PJ, Barber NJ, Bidair M, Anderson P. Water—a double-blind randomized controlled trial of aquablation vs. transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. (In press)

Rothwell PM (2005) External validity of randomised controlled trials: to whom do the results of this trial apply? Lancet 365(9453):82–93. https://doi.org/10.1016/S0140-6736(04)17670-8 PubMedCrossRef

Bach T, Giannakis I, Bachmann A et al (2018) Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort. World J Urol 2018:1–7. https://doi.org/10.1007/s00345-018-2509-y CrossRef

Leopold SS (2013) Words and meaning in scientific reporting: consecutive, prospective, and significant. Clin Orthop Relat Res 471(9):2731–2732. https://doi.org/10.1007/s11999-013-3162-9 PubMedCrossRefPubMedCentral

Desai M, Bidair M, Bhojani N et al (2018) WATER II (80-150 mL) procedural outcomes. BJU Int. https://doi.org/10.1111/bju.14360 CrossRefPubMed

Ajib K, Mansour M, Zanaty M et al (2018) Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J. 12(7):E318–E324. https://doi.org/10.5489/cuaj.4895 PubMedCrossRefPubMedCentral

Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127. https://doi.org/10.1056/NEJMsa035205 PubMedCrossRef

Lowrance WT, Southwick A, Maschino AC, Sandhu JS (2013) Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. J Urol 189(5):1811–1816. https://doi.org/10.1016/j.juro.2012.11.171 PubMedCrossRef

10.

Wilson LC, Gilling PJ, Williams A et al (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 50(3):569–573. https://doi.org/10.1016/J.EURURO.2006.04.002 PubMedCrossRef

11.

Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172(3):1012–1016. https://doi.org/10.1097/01.JU.0000136218.11998.9E PubMedCrossRef

12.

Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. https://doi.org/10.1016/J.EURURO.2010.06.005 PubMedCrossRef

13.

Yin L, Teng J, Huang C-J, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611. https://doi.org/10.1089/end.2012.0505 PubMedCrossRef

14.

Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408–411. https://doi.org/10.1111/j.1464-410X.2011.10359.x PubMedCrossRef

15.

Elshal AM, Elkoushy MA, El-Nahas AR et al (2015) GreenLight™ Laser (XPS) Photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 193(3):927–934. https://doi.org/10.1016/J.JURO.2014.09.097 PubMedCrossRef

16.

Bhojani N, Nguyen D-D, Kaufman RP, Elterman D, Zorn KC (2018) Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia. World J Urol. https://doi.org/10.1007/s00345-018-2535-9 CrossRefPubMed

Titel: Furthering the external validity of Aquablation and implications for real-world patients
verfasst von: David-Dan Nguyen
Naeem Bhojani
Kevin C. Zorn
Publikationsdatum: 02.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 9/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2610-2

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

24.04.2024 | DGIM 2024 | Nachrichten

Bei Senioren mit Prostatakarzinom auf Anämie achten!

22.04.2024 | Prostatakarzinom | Nachrichten

Stufenschema weist Prostatakarzinom zuverlässig nach

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

weitere anzeigen

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer

Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system

Redo-urethroplasty for the management of recurrent urethral strictures in males: a systematic review

Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy

SIU Newsletter - September 2019